Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 5.33% | 12.24% | 11.21% | 8.23% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 5.33% | 12.24% | 11.21% | 8.23% | |
| Cost of Revenue | 4.17% | 14.30% | 5.50% | 5.08% | |
| Gross Profit | 6.67% | 9.41% | 18.66% | 11.89% | |
| SG&A Expenses | 0.21% | 6.72% | 11.24% | 0.56% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -61.72% | -213.16% | 108.38% | 181.72% | |
| Total Operating Expenses | 1.76% | 8.90% | 7.90% | 5.11% | |
| Operating Income | 22.34% | 31.66% | 30.29% | 23.96% | |
| Income Before Tax | 40.26% | 107.46% | 49.14% | 44.53% | |
| Income Tax Expenses | 40.48% | 716.81% | 50.63% | 44.68% | |
| Earnings from Continuing Operations | 40.18% | 11.33% | 48.62% | 44.48% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | 115.60% | -- | 121.55% | |
| Net Income | 39.13% | 13.28% | 51.74% | 47.13% | |
| EBIT | 22.34% | 31.66% | 30.29% | 23.96% | |
| EBITDA | 15.61% | 23.72% | 21.95% | 17.45% | |
| EPS Basic | 40.54% | 13.69% | 47.62% | 47.09% | |
| Normalized Basic EPS | 40.43% | 36.92% | 48.74% | -- | |
| EPS Diluted | 40.54% | 13.69% | 47.62% | 47.09% | |
| Normalized Diluted EPS | 40.43% | 36.92% | 48.74% | -- | |
| Average Basic Shares Outstanding | -1.00% | -0.37% | 2.79% | 0.03% | |
| Average Diluted Shares Outstanding | -1.00% | -0.37% | 2.79% | 0.03% | |
| Dividend Per Share | -- | 9.20% | -- | -- | |
| Payout Ratio | -0.26% | -- | -0.31% | -- | |